恒健控股李明亮：国有企业如何打造基金生态圈？_行业动态_投资界 news.pedaily.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news.pedaily.cn Daily Mail and Mail on Sunday newspapers.
The Government of Singapore Investment Corp (GIC) has purchased a 5% stake in Bunge Ltd (NYSE: BG), according to a filing with the Securities and Exchange Commission.
GIC said in a filing to the SEC, that it had acquired 7.305 million shares of Bunge Ltd, valuing its stake at $496 million.
Bunge. Read More.
Marijuana plant
A new University of Adelaide trial will explore the use of personalised medicinal cannabis dosing to prevent common and impactful symptoms of treatment in advanced cancer thanks to Federal Government funding of $1.5 million.
The Medical Research Future Fund investment was awarded to Dr Hannah Wardill for the CANCAN trial – a large clinical study which aims to guide clinical practice.
“Cancer therapies are highly toxic and cause a constellation of physical and psychosocial symptoms that negatively impact quality of life, dose intensity and survival,” Dr Wardill said.
“The CANCAN trial will show that targeting gut distress, due to mucosal injury, with medical cannabis will improve patient wellbeing and maintenance of intended dosing.”Dr Hannah Wardill
大外宣計畫取代CNN、BBC 紐時曝中國正取代全球媒體格局 | 全球 nownews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nownews.com Daily Mail and Mail on Sunday newspapers.
The Potsdam, Germany-based company said Tuesday it would introduce two full-spectrum extracts, including a high THC extract and a balanced THC:CBD extract.
Iuvo Therapeutics Ltd. CEO Jonathan Lubosch-Haenisch disclosed that the products come without synthesized cannabinoids or terpenes and are strictly derived from premium GMP certified cannabis flower.
This is the largest single shipment from Australia to date,” according to Cann Group CEO Peter Crock, which he called an exciting milestone for the company. It also demonstrates Iuvo s commitment to provide its growing customer base with GMP-standard medicinal cannabis, a prerequisite for the German market, Crock added.
Iuvo is poised to become one of Europe s biggest suppliers of cannabinoid-based pharmaceuticals, with Germany holding the position of the largest medicinal cannabis market on the continent.